Tech Company Financing Transactions

Agenus Funding Round

Agenus secured a investment round on 6/3/2025. Backers included Zynext Ventures.

Transaction Overview

Company Name
Announced On
6/3/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand operations and R&D efforts to accelerate development of its lead BOT/BAL program and strategically expand into high-unmet need indications and earlier lines of treatment.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
3 Forbes Road
Lexington, MA 02421
USA
Email Address
Not Recorded
Overview
Our mission is to harness the power of the immune system to bring therapies with curative intent to individuals living with cancer. Agenus discovers, manufactures, and develops immuno-oncology (I-O) therapeutics. Our vision is to expand the patient population benefiting from I-O through combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through subsidiary MiNK Therapeutics), adjuvants and vaccines (through subsidiary SaponiQx).
Profile
Agenus LinkedIn Company Profile
Social Media
Agenus Company Twitter Account
Company News
Agenus News
Facebook
Agenus on Facebook
YouTube
Agenus on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Garo Armen
  Garo Armen LinkedIn Profile  Garo Armen Twitter Account  Garo Armen News  Garo Armen on Facebook
Chief Information Officer
Craig Winter
  Craig Winter LinkedIn Profile  Craig Winter Twitter Account  Craig Winter News  Craig Winter on Facebook
Chief Marketing Officer
Stefanie Perna-Nacar
  Stefanie Perna-Nacar LinkedIn Profile  Stefanie Perna-Nacar Twitter Account  Stefanie Perna-Nacar News  Stefanie Perna-Nacar on Facebook
Chief Medical Officer
Steven O'Day
  Steven O'Day LinkedIn Profile  Steven O'Day Twitter Account  Steven O'Day News  Steven O'Day on Facebook
President
Jennifer Buell
  Jennifer Buell LinkedIn Profile  Jennifer Buell Twitter Account  Jennifer Buell News  Jennifer Buell on Facebook
VP - Bus. Development
Richard Goldberg
  Richard Goldberg LinkedIn Profile  Richard Goldberg Twitter Account  Richard Goldberg News  Richard Goldberg on Facebook
VP - Bus. Development
Robin Taylor
  Robin Taylor LinkedIn Profile  Robin Taylor Twitter Account  Robin Taylor News  Robin Taylor on Facebook
VP - Finance
Christine Klaskin
  Christine Klaskin LinkedIn Profile  Christine Klaskin Twitter Account  Christine Klaskin News  Christine Klaskin on Facebook
VP - Human Resources
Tracy Clemente
  Tracy Clemente LinkedIn Profile  Tracy Clemente Twitter Account  Tracy Clemente News  Tracy Clemente on Facebook
VP - Manufacturing
Alfred Dadson
  Alfred Dadson LinkedIn Profile  Alfred Dadson Twitter Account  Alfred Dadson News  Alfred Dadson on Facebook
VP - Regulatory Affairs
Eric Humes
  Eric Humes LinkedIn Profile  Eric Humes Twitter Account  Eric Humes News  Eric Humes on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/3/2025: Valla venture capital transaction
Next: 6/3/2025: Impulse Space venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to document every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary